The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. - Wikidata - awgldk - TriplyDB

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.

http://www.wikidata.org/entity/Q35032285

about

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

P2860

Q41600132-824B6217-D39F-4630-A7BD-6BEF739BBD1A Q45071301-DC689FC2-4F40-437F-BF41-663D510235D0

P2860

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.

http://www.wikidata.org/entity/Q35032285

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@ast

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@en

type

label

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@ast

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@en

prefLabel

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@ast

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@en

P1433

Q35032285-D5A34040-D6DB-4CD4-B882-2D7883B2CB61

P1476

Q35032285-DE93A4E5-48C6-455C-A029-B345DC0CB9DB

P2093

Q35032285-0B9DA969-83FC-44FA-9685-C688FA95AAF7

Q35032285-5B5DFC2D-ED49-4E18-9313-3BBD84A8FA7A

Q35032285-8431BD6F-A748-451E-80F2-E8DAC45375FE

Q35032285-B166B5A4-6468-4D8B-AA47-E564A07CD605

Q35032285-B54E5150-E1B9-4A7A-87D2-0D6A1AFB0678

Q35032285-BA733377-E0AE-47BC-A77E-7A625B4A7F99

Q35032285-D8164FE3-8B07-4933-8767-2CCD1D408228

Q35032285-F129A4A9-3320-4A46-9077-593E2D4379F6

Q35032285-F2B9CA52-8340-4903-9FDA-DFD5F552AC0E

P2860

Q35032285-01E815F8-08F6-4C0D-8AB6-4E15485E7151

Q35032285-1386B8D4-9DE1-43D2-9B36-37D3B9E4E4EF

Q35032285-1E7FA26D-85D9-4091-A586-08C892ACE637

Q35032285-2AE54B79-55CB-4604-9054-632A62C2AA5C

Q35032285-2BD28F76-14C9-4821-B5E1-F0162835D0B3

Q35032285-3712345A-B129-4C0F-BFD0-F3EC2F6EAB01

Q35032285-39AB1025-741E-494F-9D84-D754AC3E3CDE

Q35032285-47A94951-1B08-415D-B735-FC826B561AE3

Q35032285-5435A651-A30E-460F-9099-AE81B9F15E69

Q35032285-5BA6E823-16D7-4CD7-9429-BEBB0DD260B0

P304

Q35032285-F9B7E05A-F7BF-4ACA-913D-27D00303E409

P31

Q35032285-B5874267-0D48-423C-ABDF-39567D59F88E

P356

Q35032285-E73C1D68-4B27-41B6-AFE9-6004A3466DB5

P407

Q35032285-91845942-2E3B-4FA8-9368-3BC003D3B6FA

P433

Q35032285-082D00C7-C91A-4E99-905F-3B938F5C40DD

P478

Q35032285-D42E3E24-6718-4F50-9126-132BD4C66566

P50

Q35032285-5E752043-071A-4624-9BDA-43216390A073

P577

Q35032285-3EA126B7-E5B0-4989-9189-BF7C0E33BFBB

P5875

Q35032285-D4555335-DC88-433C-BA6A-49B7B24EF0B0

P698

Q35032285-E76FF43D-909F-4538-A7B7-782544B1C4E8

P932

Q35032285-565FB74C-D906-482D-A4EF-D2070E1CFD53

P356

P1433

Cancer Medicine

P1476

The role of FDG-PET imaging as ...... y mediastinal B-cell lymphoma.

@en

P2093

Drew A Torigian

http://www.w3.org/2001/XMLSchema#string

Eli Glatstein

http://www.w3.org/2001/XMLSchema#string

Elise A Chong

http://www.w3.org/2001/XMLSchema#string

Jakub Svoboda

http://www.w3.org/2001/XMLSchema#string

Nirav N Shah

http://www.w3.org/2001/XMLSchema#string

Sarah J Nagle

http://www.w3.org/2001/XMLSchema#string

Seble Chekol

http://www.w3.org/2001/XMLSchema#string

Stephen J Schuster

http://www.w3.org/2001/XMLSchema#string

Sunita D Nasta

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Primary mediastinal B-cell lymphoma.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

P304

7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.322

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

John P Plastaras

P577

2014-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265514192

http://www.w3.org/2001/XMLSchema#string

P698

25205600

http://www.w3.org/2001/XMLSchema#string

P932

4312112

http://www.w3.org/2001/XMLSchema#string